SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor...

Leukemia 2011 / 11 Vol. 25; Iss. 11

SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies

Hart, S, Goh, K C, Novotny-Diermayr, V, Hu, C Y, Hentze, H, Tan, Y C, Madan, B, Amalini, C, Loh, Y K, Ong, L C, William, A D, Lee, A, Poulsen, A, Jayaraman, R, Ong, K H, Ethirajulu, K, Dymock, B W, Wo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2011.148
Date:
November, 2011
File:
PDF, 625 KB
english, 2011
Conversion to is in progress
Conversion to is failed